Did you mean: every the?

  • Xolair® (omalizumab)

    Allergy Asthma Children 6 to < 12 years of age Xolair is indicated as add-on therapy to improve asthma control with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and frequent daytime...

  • Dosing and administration

    Instructions for use of Xolair Pre-Filled Syringe

    Discover how to reconstitute XOLAIR and calculate the right dose for your severe allergic asthma or chronic rhinosinusitis with nasal polyps (CRwNP) patient...

  • Gilenya® (Fingolimod)

    Indication Gilenya is indicated as disease-modifying monotherapy in highly active relapsing-remitting multiple sclerosis (RRMS) in the following groups of adult and paediatric patients aged 10 years and older: • patients with highly active disease...

  • About COPD

    Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder characterized by persistent and progressive airfow obstruction, affecting 6–10% of adults worldwide[1]. In the Asia–Pacific region, the prevalence of COPD was estimated as...

  • Webinars

    Xpert Sharing Webinars

    Thank you for your interest in severe allergic asthma webinars with Novartis. Though you missed the live presentation, we are delighted to provide you with the recording of this informative session, so you can view on demand at...

  • Myelofibrosis Disease

    Myelofibrosis (MF) is one of the classical types of Philadelphia (Ph) chromosome-negative myeloproliferative neoplasm (MPN). Due to clonal proliferation of pluripotent hematopoietic stem cells, MF...

  • About Galvus

    Galvus is a novel oral antidiabetic drugs belongs to the class of DPP4i. Galvus contains Vildagliptin and it is indicated in the treatment of type 2 diabetes mellitus, either as a...

page 

Pages

 of  2
×

Ask Speakers

×

Medical Information Request